chrisvoncsefalvay/vaers-outcomes huggingface dataset:
rash at the injection site, and it is itchy; chills; aches; a lump on the arm of the injection ( Left arm); muscle aches; joint pain; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches) and ARTHRALGIA (joint pain) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension (No reported medical history) and Hyperlipidemia.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea). On 06-Apr-2021, the patient experienced RASH PRURITIC (rash at the injection site, and it is itchy). The patient was treated with PARACETAMOL (TYLENOL) on 02-Apr-2021 at an unspecified dose and frequency and CORTISONE ACETATE (CORTISOL [CORTISONE ACETATE]) on 06-Apr-2021 at a dose of UNK,Cortisol cream at the injection site. At the time of the report, CHILLS (chills), PAIN (aches), VACCINATION SITE MASS (a lump on the arm of the injection ( Left arm)), MYALGIA (muscle aches), ARTHRALGIA (joint pain) and NAUSEA (nausea) had resolved and RASH PRURITIC (rash at the injection site, and it is itchy) outcome was unknown.            The action taken with mRNA-1273 in response to the event was not applicable. Concomitant medications included blood pressure and cholesterol medication.
I had absolutely no pain nor any reaction from first Pfizer shot.  A few hours after the second shot, my arm hurt.  A little later I felt achy, but still was up for going out to dinner with friends.  Woke up that night with pretty big pain in injection arm.  It was a little less than the pain when I got the actual injection.  Next morning I was achy all over and arm still hurt pretty bad.  Started Tylenol (3x in 24 hours - - which I never take) and had a day of pjs in bed.  Achy most of the day.  No fever though.  Woke up today with no pain at all in injection arm and no body aches!  All was very manageable, but wanted to report for science.  #thankyouscience
Information was received from a third party claims management company who represented a pharmacy. A male of unknown age received PNEUMOVAX 23 (Lot # L012215, Exp. 13JAN2017) on 05-OCT-2015 and shortly after developed a rash at the injection site. The pharmacy quarantined the vial. The outcome of the rash at the injection site was unknown. Additional information has been requested.
COVID-19 vaccine second shot three weeks after the first shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (COVID-19 vaccine second shot three weeks after the first shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (COVID-19 vaccine second shot three weeks after the first shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (COVID-19 vaccine second shot three weeks after the first shot) outcome was unknown. Not Provided          No  concomitant medical  provided by the reporter. No treatment medication provided by the reporter.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was Not applicable.
Soreness at injection site, but on the 2nd day after the injection the pain is now down to my elbow but mostly in my armpit. My armpit is swollen and so tender that even putting deodorant on hurts. Sharp pains, than throbbing. Today is day 4 after injection and pains and swelling still in my armpit and at injection site. At day 8 all symptoms are mostly gone.
not feeling well; This is a spontaneous report received from a contactable consumer for a Pfizer sponsored program.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MALAISE (non-serious), outcome "unknown", described as "not feeling well".  Additional information: The reported mentioned that her parents were scheduled to receive their second dose but they would not be able to get it since they were not feeling well.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021444923 same suspect drug and similar event on different patients
Pt recv vax on 6/15/98; on 4/8/99 pt exp chicken pox on stomach, chest, back
Received the first dose of Moderna on April 17,2021 at a educational facility, on her right arm and has developed a round yellow dot on the shot she got it is full of liquid she would like to know what she needs to do.  No fever or chills just a pain in the arm which is normal .
Pt had flu vaccine month ago by mistake RPH gave her another one instead of shingles vaccine.
tingling in face and arms; joint pain; constantly throwing up; anxiety; stomach pain; something for IBS; This is a spontaneous report from a contactable consumer. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number and expiration date: Not reported), via an unspecified route of administration, on 18Apr2021 (at the age of 37-year-old) (at 15:00), in Arm Right, as dose 1, single for COVID-19 immunization. Medical history included, diagnosed allergies, compromised immune status, respiratory illness, genetic / chromosomal abnormalities, endocrine abnormalities (including diabetes) obesity, ongoing chronic nausea. Concomitant medication(s) included ondansetron taken for chronic nausea, start and stop date were not reported. The patient previously took promethazine (PHENERGAN) for allergy. The patient went to the hospital last night because got so sick an hour after getting the vaccine. Reporter stated that the patient was experiencing tingling in her face and arms, severe joint pain and was constantly throwing up. The patient cannot keep anything down. The reporter took patient to the emergency room. In emergency room the patient was given with rehydration in IV fluids, something for IBS and to calm stomach pain that caller doesn't remember, as well as Zofran, Benadryl and Ativan because patient's anxiety shot through the roof. Patient's labs all came back normal so the emergency room decided to send her home, which the reporter was not very happy about, but he could not do anything about. The reporter stated that these symptoms were all ongoing and consistent. He confirmed the anxiety has not gotten any better. The reporter reported that patient had chronic nausea but it did not usually come on like this did, usually Zofran stops the nausea but it had not worked so far. Patient went to emergency room as a result of AE. Treatment was taken with rehydration in IV fluids, something for IBS, Zofran, Benadryl and Ativan. The clinical outcome of events anxiety, abdominal pain, nausea were unknown while remaining events were not recovered.  No follow-up attempts are needed. No further information is expected.
After vaccination patient was instructed to remain seated.  He was asked if he was feeling alright and he stated he was.  About 3 minutes after receiving the vaccines he fell out of the chair and onto the floor.  The nurse assisted him to a semi-sitting position and another nurse provided smelling salt ampule.  Patient had an immediate response and was conscious and verbally responsive.  Cool towels were provided to his forehead and his feet were elevated. PHNs monitored him for the next 30 minutes, gradually assisting him to chair, standing and ambulating.  He was assessed for any injury and none were noted.  He was able to move all extremities without complaints.  It was noted he had an empty stomach prior to vaccination and he was provided with sips of cola.  Both patient and parent were instructed to make sure he eats prior to any immunizations in the future.  He was assisted to the car and was able to walk without problems.  PHN made a follow up call the the parent on 9-20-2010 and his mom states he is doing well, the incident scared them and she was thankful for the call.
Information has been received from a consumer who is a 32 year old female patient with seasonal allergies and no relevant medical history who in approximately 2001 was vaccinated with two doses of varicella virus vaccine live and had blood work done that showed no antibodies. There was no concomitant medication. Unspecified medical attention was sought.
Narrative:  pt received first dose shingrix on 4/5/18. after 2nd dose on 7/9/18 c/o flu like symptoms.
Information has beenreceived from a physician concerning a 76 year old female patient with "tetanus shot" allergy (rash) who on 04/27/01 at 11:00 was vaccinated in the left deltoid with the first dose of pneumococcal vaccine 23 polyvalent (lot 635892/1197K). Concomitant therapy included alendronate sodium and celecoxib (Celebrex). On 04/17/01, as soon as the patient left her physician's offices, the injection site became swollen, red and itchy. This feeling spread to her inner arm and elbow and her arm became painful to the touch and yellow in color. Subsequently, the patient's arm felt better but was still a little swollen. Thepatient did not seek medical attention. No further infotrmation is available
Information has been received from a pharmacist regarding to a patient of unknown age and gender. On an unspecified date, the patient was vaccinated with, 0.65 ml dose of ZOSTAVAX (route and lot number were not provided), injection, to prevent shingles. No other co-suspects were reported. No concomitant medications were reported. On an unknown date, the patient developed nausea after getting ZOSTAVAX. No rash was reported. The patient sought medical attention. No treatment information was reported. The patient's outcome was unknown. This is one of several reports from the same source. Additional information has been requested.
Itching on Rt arm. Erythema + 5cm on Rt arm. No pain or tenderness no swelling.
A big red welt with a darker ring around the outside; Localized pain; normal vaccine side effects; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (normal vaccine side effects), VACCINATION SITE URTICARIA (A big red welt with a darker ring around the outside) and VACCINATION SITE PAIN (Localized pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy, Hay fever and Allergy to animal dander (cat).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced VACCINATION COMPLICATION (normal vaccine side effects) and VACCINATION SITE PAIN (Localized pain). On 22-Feb-2021, the patient experienced VACCINATION SITE URTICARIA (A big red welt with a darker ring around the outside). In February 2021, VACCINATION COMPLICATION (normal vaccine side effects) and VACCINATION SITE PAIN (Localized pain) had resolved. At the time of the report, VACCINATION SITE URTICARIA (A big red welt with a darker ring around the outside) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  It was reported that the welt did not hurt and the patient has history of getting welts when taking allergy shots.  Patient used little ice on days one and two for the normal side effects of vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up report included no new information
Patient stated she was given COVID vaccine at an assisted living facility for which she works. Within minutes of being given the vaccine, she broke out in a rash. She stated Benadryl was given.  She began feeling nauseous, vomiting, and "felt like crap" within 1 hour of vaccine administration. She stated to her knowledge no one administering the vaccine completed a VAERS form or even asked for her name.  She has felt myalgia, respiratory discomfort, and nausea since and came to my clinic today seeking resolution of symptoms.
Went to the ER experiencing chest pain 2 weeks after my second shot. Was told my heart is enlarged and was diagnosed with pericarditis. I am experiencing shortness of breath and exhaustion.
Took claritin 10 mg at 0600 am that morning, took a second dose of claritin at 1230pm and hour before injection of Moderna Covid 19 vaccine.  50 minutes after the injection throat started feeling tight and increased in pressure, swallowing reflexively increased, no shortness of breath. Took 25 mg benadryl and Proair inhaler. Feeling of throat tightness started to relieve within 20 minutes. No further problem with the throat tightness after that. Asthma flared slightly after injection but controlled with routine asthma meds.
Patient reported soreness in her arm and that it was hard to lift. I told her to ice her arm and take a otc pain medication. She will call back with any issues.
No adverse effect; Improperly stored dose of varivax; This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. The medical assistant described on 05-NOV-2019, one improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) (product storage error), lot # R030604 with expired date 23-OCT-2020, (strength, dose, route were not reported) for prophylaxis was administered to patient. No adverse effects and no product quality complaint reported.
Lymph node under left arm very swollen to present date and sore. Left arm at injection site is very red still and swollen.
Headache, Myalgia, Fever, FEVER (100.8) FATIGUE, BODY ACHE, HA, METTALLIC TASTE Narrative:  Other Relevant History:
p/vax pt c/o shortness of breath & hive like rash on both legs & back; seen by MD
3/16 Sore Arm - lasted 24 hours or so 3/20 Lymph Nodes in Left Armpit swollen. Slight numbness in fingers. Uncomfortable to put my arm down normally due to pain in arm pit. - lasted 24 hours or so 3/22 Injection Site a bit itchy 3/23 Injection Site very itchy with red hives - lasted three days
1755 lite headedness, pale, BP 92/40 HR 68 reg. - BS 163 O2 sat 99%.
Rash on abdomen and back; Sweating; severe muscle ache; severe joint ache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0187) via an unspecified route of administration in the left arm on 25May2021 at 08:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient previously received amoxicillin, clavulanic acid (AUGMENTIN) on an unspecified date for an unspecified indication and experienced drug allergy. The patient did not take any other medications within two weeks. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Apr2021 at 08:30 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 (12-36 hours after vaccination), the patient experienced sweating, severe muscle and joint aches. On 26May2021, the patient experienced rash on abdomen and back. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sweating, severe muscle and joint aches and rash on abdomen and back was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
I had severe body and head aches the day following the booster vaccine. I became very dizzy and lightheaded on the third day following  vaccination.  Today (6 days post vaccination) I was hospitalized because of dizziness, disorientation, peripheral numbness, and cyanosis.
Seen in ER 4/15 for chest pain felt c/w possible pericarditis
Sudden onset of severe pain in the shoulder and upper arm a little over 48 hours after the vaccine was administered. As of this report pt. is unable to raise her left arm by the shoulder, but is able to bend the elbow and retains sensation in and use of the hand.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2014, a pharmacist administered the ZOSTAVAX (dose, route, and lot # not provided) to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related injuries. In 2015, the patient was treated by a healthcare provider for Shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the event was not recovered/not resolved. Causality assessment was related.
She presented to the ER on 04/07/21 with chest pain. Her niece was nurse, took her blood pressure and that was running high with chest pain and high blood pressure and some back pain that was going on for 2 days. She decided to seek help. The substernal pain was radiating to her shoulders, but also got worse with deep breathing and was quite intense. At the hospital, she developed worsening back pain and difficulty with ambulating. Over the next day or so, her neurological weakness got worse with ascending up to her legs, and then she also had progressive facial weakness with trouble swallowing and speaking.
Patient came back 3 days after received ZOSTAVAX, FLUZONE-High Dose, and PNEUMOVAX 23 vaccines on 10/12/16 with redness (approximately 1.5 in diameter) by ZOSTAVAX site and diffused rash by flu and pneumonia site. Fever of 103 degrees F reported day after vaccination.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 22-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication details was provided. No treatment medication details was provided. The vaccines was stored in freezer, we take out one to two vials and place in fridge each day as needed PI removed
Pt recvd Engerix-B on 1JUN92 & 10mins p/receiving 1st dose of vax devel h/a, nausea & shaking;
Scalp and ears itching and tingling at first. Within days, nerve pain at waist. Sporadic nerve pains continued for several weeks & became worse. By 3-4 wks. after, severe nerve pain (sometimes numbness) in buttocks, tailbone, upper thighs, right leg shooting to foot, genitals. Urinary retention. Nerve pains in eyes & nose. By late May facial pressure & tingling, abdominal distension & digestive problems, peripheral neuropathy (hands & feet). Prednisone (two courses) ineffective. 2nd course of prednisone accompanied by worsened symptoms. Multiple antihistamines tried; help only minimally. Symptoms have continued to the present.
Vaccine Recipient stated that she started to see black, her hearing was squeaky, and her body felt heavy. The vaccine recipient was immediately laid supine on the floor. After three minutes she stated she felt better and wanted to move to a sitting position. After an additional five minutes she was moved to sitting on the bench of the lunch table. At 11:30AM the school nurse released the vaccine recipient to her lunch period.
Small vesicular rash on 3 of 5 left distal phalanges as well as supra-pubic region.  This developed Newest blister developed within past 1-2 days in pad between thumb and index finger.  Pt received a steroid injection in PCP's office on 7/30.
Recipient developed an itch rash on arms and torso 2 weeks after vaccination. Unknown origin as there was no other dietary or medication change nor environmental exposures.
headaches; chills; little bit of a temperature; body ache/pain; This is a spontaneous report from a contactable consumer (patient).   A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EP7534), via an unspecified route of administration, administered in Left arm on 25Mar2021 19:00 (at the age of 54 year old) as dose 2, single for COVID-19 immunisation.  The patient medical history, family history and concomitant medications were reported as none. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number EN6205 , via an unspecified route of administration in left hand on 04Mar2021, as single dose for COVID-19 immunization. On 25Mar2021, she got the second shot of the vaccine. The first day and a half after the vaccine, on 26Mar2021, she was having chills, a little bit of a temperature, body aches and she was kind of okay but had pains here and there. On 28Mar2021 she had headache, where it was not bad, as the day went on, it got worse. For the past 2 days (29Mar2021, 30Mar2021), she has been having bad headaches. Last night (on 30Mar2021 night) she took two Advil (strength 200mg, Lot Number: 3532417, expiry: Feb 2022) at 1:00 and woke up at 5:00. Even though she slept four hours, her head was still hurting. At 7:00, in the morning on 31Mar2021, she took two extra strength Tylenol (500mg each, Lot Number: SBA051, expiry: Dec 2021) and still has headache at the time of report. No relevant test had done. The outcome of the event headache was not recovered and of other events was unknown.   No follow-up attempts are possible. No further information is expected.